Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of MacroGenics, Inc. (“MacroGenics” or the “Company”) (NASDAQ: MGNX) between February 6, 2019 and June 3, 2019, inclusive (the “Class Period”).
September 17, 2019
· 3 min read